U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07072403) titled 'Trametinib Treatment for Complicated Vascular Anomalies' on July 07.
Brief Summary: Complicated vascular anomalies have diverse etiologies and variable clinical manifestations, and no standardized treatment protocol has been established. Since most patients present with diffuse lesions that are difficult to resect surgically, identifying effective therapeutic strategies is of critical importance. This study aims to evaluate the safety and efficacy of systemic trametinib therapy in patients with complicated vascular anomalies.
Study Start Date: July 07
Study Type: INTERVENTIONAL
Condition:
Vascular Anomalies
Intervention:
DRUG:...